We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Intelsius Launches New Patient Safety Products
Product News

Intelsius Launches New Patient Safety Products

Intelsius Launches New Patient Safety Products
Product News

Intelsius Launches New Patient Safety Products

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Intelsius Launches New Patient Safety Products"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Intelsius has announced the launch of its new Thermotrek™ range of products.

Thermotrek systems are a range of insulated, patient carry cases designed for movement of temperature sensitive medications either being tested in clinical trials or for approved and marketed medicines used by patients.

The success or failure of clinical trials often depends on crucial passive climate controls to ensure the efficacy of medicines.

In commercially available temperature sensitive medicines the systems ensure the patient’s investment in treatment is not wasted while ensuring efficacy of the medicine.

Thermotrek systems are qualified to maintain contents at the required temperature for up to 24 hours and designed to give many months of use.

The first two Thermotrek solutions are constructed with proprietary materials which provide a high level of resistance to tears or abrasions while providing stain and water resistance.

Each case is ergonomically designed to have a minimum impact on the patient’s daily life and enable comfortable transportation of medicine.

In addition, its discreet design keeps the contents confidential. With the Thermotrek range, Intelsius continues to lead the way in developing solutions that ensure patient safety.

“Keeping patients safe and helping ensure successful clinical trial outcomes are the primary reasons for creating the Thermotrek line of products,” said David Walsh, chief executive officer of Intelsius.

Walsh continued, “We are proud to lead the way in the effort to provide easy to use, technically advanced solutions to the life science industry,” said Walsh.